That is very important, because the way a protein in the body folds identifies if a pharmaceutical will have the ability to bind to that protein and work. In other words, we have to understand how these proteins fold if we want a drug to work. Historically, this has actually been an experimental procedure (jeff brown biotech genome sequencing). And now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're developed to do. This was a development nearly nobody discovered. However it's going to have extensive ramifications for curing illness. I predict that Alpha, Fold will be 98% accurate by the end of 2021.
And, naturally, there will be lots of financial investment chances in this area, too. Shifting subjects It's going to be a good year for bitcoin. I'm bullish on it in 2021 (biotech stock). That stated, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be amazed if it drew back possibly significantly before going higher - exponential tech investor. I have actually been covering bitcoin for a long time now. One of the very first research reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial recommendation, I titled my report "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time. We were mostly educating readers. But that's not the huge question anymore. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, niche business. Mass, Mutual is a relied on 170-year-old institution. So think of that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
And that's a big reason I'm bullish on it this year. the legacy report prediction. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These business raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I forecast 2021 will be another record year in IPOs. There are many terrific private business on the brink of striking the general public markets And I have actually been dealing with a brand-new way for you to invest even before these companies go public.
This chance has been building over the last couple of years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to discover all the information. Go right here to reserve your spot free of charge.
Emma Walsh here, handling editor of the Journal. Regular Journal readers understand that tech isn't our typical beat (brownstone research). And when it pertains to tech investing, we leave it to the professionals. The good news is, we have several such professionals in our Rolodex. Our coworker Jeff Brown will be familiar to our long time readers. He is among the most accomplished tech investing professionals we understand (genetic sequencing companies jeff brown). In reality, he had numerous triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the big photo and anticipate what's simply around the corner.
That consists of things like 5G networks, biotech, expert system, and a lot more. These patterns are experiencing rapid development and developing incredible chances for financiers. I wish to ensure all our readers are prepared for what's next. And with that in mind, let me draw the picture of what I see being available in the next 12 months Our new 5G (fifth-generation) wireless networks are a subject I have actually been covering for years now. jeff brown stock predictions 2021. But in spite of what many readers may think, this is a trend that's simply getting going. Although the COVID-19 pandemic interrupted supply chains in 2015, an outstanding 250 million 5G-enabled gadgets were still offered.
And all of this ultimately caused Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (jeff brown predictions for 2021). Losing two months of manufacturing and sales truly impacts how lots of 5G gadgets are sold in the fiscal year. When you think about all of that, selling 250 million systems is remarkable. More importantly, the hold-ups brought on by the pandemic developed a lots of bottled-up need. And that need is now going to be pressed into 2021. In reality, I predict that more than 500 million 5G devices will be delivered in 2021 - the legacy report predictions. Which's not my only 5G forecast When I have actually spoken about 5G in the past, I have actually explained its 3 different stages.
In Phase Two, 5G gadgets go on sale. 5G phones and other products start to reach customers. And in Stage 3, 5G services begin to be offered (exponential tech investor). That's when we start to see applications running on 5G networks. Think about things like huge multiplayer games over a mobile phone. That's not possible with 4G. It will be with 5G. And my second 5G prediction for 2021 is that we will begin Stage 3 by this summer season. This begins something of a virtuous cycle: The majority of people don't truly care about the technology. However they will care if there are amazing applications that can just be accessed with a 5G phone.
That leads to more 5G apps being established. In reality, 5G is going to open a suite of amazing applications: self-driving automobiles, the Internet of Things, robotic surgical treatment, and more. All of these innovations require 5G. The financial investment chances moving forward will be enormous. Stepping far from 5G, the next crucial technology I anticipate in 2021 is CRISPR genetic editing. CRISPR represents "clustered routinely interspaced short palindromic repeat." It's a mouthful. However it's one of the most interesting developments in biotechnology. At a high level, CRISPR is a technology that can edit our hereditary makeup as if it were software.
The program can crash or not operate correctly. CRISPR uses a comparable idea but with our hereditary code. "Typos" in our genome can result in disease. CRISPR can fix these "typos." For several years, CRISPR was mainly a niche innovation that wasn't well comprehended. And during that time, there were actually just 3 business operating in this area. But things are changing. CRISPR is no longer just theoretical. We're seeing actual results. We're dealing with illness and seeing that this innovation simply works. And as a result, a "second crop" of early-stage CRISPR companies is going public and providing amazing returns. This entire market is effectively a greenfield chance.
There's room for numerous business to exist in this area. jeff brown genome sequencing stock. And there will be more. That's my forecast for CRISPR in 2021. I anticipate that two or three more genetic modifying companies will hold their IPOs. Sticking to biotechnology, we are seeing fantastic things taking place at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its newest Alpha, Fold software application can precisely anticipate the folding of a protein based solely on its amino acid series with 92. 4% accuracy. That's important because the way a protein in the human body folds determines if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has been a trial-and-error procedure. Today, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're developed to do. And here's my next forecast. I forecast that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one however several drug treatments produced using this innovation. This was one of those developments that practically nobody discovered. However it's going to have extensive implications for treating illness. And, of course, there will be lots of investment chances in this space, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be amazed if it drew back maybe considerably prior to going higher. I've been covering bitcoin for a long period of time now. Among the very first research study reports I ever released was on bitcoin - jeff brown genetic sequencer stock. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anybody who followed my suggestion. However at the time of that preliminary recommendation, I titled my report, "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time.
But nobody is asking that concern anymore. Now, we're seeing institutional money finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche business. artificial intelligence. Mass, Mutual is a 150-year-old institution. So consider that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another perk forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and claims the details depends on date since February 2021, but we could not individually verify this claim. Offered Jeff Brown's past, he likely has a considerable net worth, however we can't hammer down a precise figure at this moment. Brown is best known for his sage-like capability to pick winning technology stocks. He invested more than 25 years researching innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience offers him an excellent viewpoint on the marketplace. He's constantly on the hunt for new opportunities, and he shares a lot of his best picks in the Future Report.
That's high praise, but it's not absurdly reasoned. Brown has an exceptional track record as a stock-picker, and he successfully anticipated a few of the biggest economic occasions of the previous twenty years. Although he doesn't appear to release his picks to the public, the service's success is a direct indication of Brown's stock-picking expertise. No one on Wall Street gets it ideal whenever, but Jeff Brown's precise predictions have made him legions of dedicated fans. That says a lot about his capability. The Future Report is released by Brownstone Research, a prominent monetary research study publisher. Brownstone Research study offers several research services with a large variety of specializations - artificial intelligence.
The company is also connected with Bonner & Partners, another well-respected research publisher - the legacy report prediction. On its site, Brownstone states its objective is to supply retail financiers with professional-grade research: "For too long, the finest financial investment research has actually not been readily available to specific investors. It has been normally booked for financial investment banks, hedge funds, personal equity, and high-net-worth customers. brownstone research stock. The mission of Brownstone Research study is to make that kind of exclusive research study available to any investors seeking to gain an edge in the marketplaces. The goal is simple to provide distinct and rewarding financial investment research discovered nowhere else." -Brownstone Research site excerpt from the Jeff Brown is the founder of Brownstone Research, and he likewise works as the company's Chief Financial investment Analyst.
With Brown directing the ship, Brownstone Research study is a powerhouse publisher with lots to use its customers. After decades of constant success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a home name throughout the majority of America. If you understand even a little bit about the marketplace, you know that he has a track record as a King Midas of sorts. exponential tech investor. Everything he touches turns to gold! Jeff is well mindful of Elon Musk's executive prowess, so he constantly has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big task.
In reality, Brown thinks S.A.V. melania trump. could be "the most significant pattern of the 2020s, and he's not alone. Check out these quotes from other widely known S.A.V. bulls: Elon's next huge act will be weding two advanced technologies: expert system and electric automobiles. Musk hopes the mix will help him develop the first fully-autonomous, self-driving automobiles ever. It's absolutely nothing short of the automotive industry's Holy Grail. As you know, electrical vehicles and self-driving vehicle stocks have been huge this year, however the Wall Street device has actually approved hype without much concrete outcome. Despite an extreme increase in competitors over the previous couple of years, Brown still thinks Musk has the very best possibility of putting it all together.
tech could be the magic string that ties all of it together. S.A.V. represents Shared Autonomous Car, and it could be the future of transport. Basically, this innovation would permit you to rent your car as a self-governing, self-driving taxi when you're not using it. You merely get out of the automobile and press a button on an app that tells the car to "sign up with the fleet." Next thing you know, you're relaxing on your couch while your automobile shuttles ride-sharers around town. Best of all, you get to keep a hefty portion of the revenues. It sounds ridiculous, however it could be closed than you think.